Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase.
D000236:Adenoma / Q000188:drug therapy*; D000262:Adenylyl Cyclases / Q000378:metabolism; D004533:Egtazic Acid / Q000494:pharmacology; D005768:Gastrointestinal Hormones / Q000627:therapeutic use*; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D011388:Prolactin / Q000378:metabolism*; D014660:Vasoactive Intestinal Peptide / Q000627:therapeutic use*
D005768:Gastrointestinal Hormones; D014660:Vasoactive Intestinal Peptide; D004533:Egtazic Acid; D006160:Guanosine Triphosphate; D011388:Prolactin; D000262:Adenylyl Cyclases